Saudi Arabia Dengue Vaccines Market Analysis

Saudi Arabia Dengue Vaccines Market Analysis


$ 3999

Saudi Arabia Dengue Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing dengue burden globally, growing awareness and government initiatives, technological advancements in vaccine development, economic burden reduction, and collaborative efforts between vaccine manufacturers, research organisations, and government agencies are driving the Dengue Vaccines market. Sanofi Pasteur, Takeda Pharmaceutical Company Limited, Butantan Institute, Biological E. Limited, Merck & Co., Bharat Biotech International Limited, Panacea Biotec Limited, GlaxoSmithKline plc, GeneOne Life Science Inc., Inviragen (a subsidiary of Takeda Pharmaceutical Company Limited) are among the global key players in Dengue Vaccines Market.

ID: IN10SAPH268 CATEGORY: Pharmaceuticals GEOGRAPHY: Saudi Arabia AUTHOR: Aneri Parekh

Buy Now

Saudi Arabia Dengue Vaccines Market Analysis Summary

Saudi Arabia Dengue Vaccines Market is valued at around $7.6 Mn in 2022 and is projected to reach $21.7 Mn by 2030, exhibiting a CAGR of 14.1% during the forecast period 2023-2030.

The disease is a highly contagious vector-borne disease. The increasing dengue burden globally, growing awareness and government initiatives, technological advancements in vaccine development, economic burden reduction, and collaborative efforts between vaccine manufacturers, research organizations, and government agencies are driving the Dengue vaccine market. Sanofi Pasteur, Takeda Pharmaceutical Company Limited, Butantan Institute, Biological E. Limited, Merck & Co., Bharat Biotech International Limited, Panacea Biotec Limited, GlaxoSmithKline plc, GeneOne Life Science Inc., Invitrogen (a subsidiary of Takeda Pharmaceutical Company Limited) are among the global key players in Dengue Vaccines Market.

Market Dynamics

Market Growth Drivers

  1. Rising Dengue Burden: The rising prevalence of dengue infections globally is a major market driver, highlighting the need for effective preventive measures such as vaccinations
  2. Growing Awareness and Government Activities: Dengue awareness campaigns and government initiatives, such as immunization programs, contribute to market growth
  3. Advances in vaccine technology, such as the creation of live attenuated and recombinant vaccines, have improved the chances for dengue vaccinations
  4. Economic Strain Reduction: Dengue epidemics place a large financial burden on healthcare systems, and vaccinations provide a cost-effective way to reduce dengue-related healthcare expenses
  5. Collaborative Efforts: Public-private partnerships and collaborations between vaccine manufacturers, research organizations, and government agencies accelerate vaccine development and market growth

Market Restraints

  1. Concerns about vaccination safety and efficacy: Safety concerns about vaccine adverse events or the perception of side effects might limit vaccine adoption and uptake. Dengue is caused by four serotypes, and creating a vaccine that provides broad and long-term protection against all serotypes remains difficult
  2. Affordability and Accessibility: Making dengue vaccines affordable and accessible, particularly in low-income areas, can be difficult

Competitive Landscape

Key Players

  • Sanofi Pasteur
  • Takeda Pharmaceutical Company Limited
  • Butantan Institute
  • Biological E. Limited
  • Merck & Co.
  • Bharat Biotech International Limited
  • Panacea Biotec Limited
  • GlaxoSmithKline plc
  • GeneOne Life Science Inc.
  • Inviragen (a subsidiary of Takeda Pharmaceutical Company Limited)

Development in Dengue Vaccines Market

  • Janssen’s JNJ-64281802 tablets are under phase 2 study for the prevention of dengue infection. The study is estimated to be complete by 2025.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Saudi Arabia Dengue Vaccines Market Segmentation

By Vaccine Type

  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • Subunit Vaccines

By End User

  • Pediatric and Adult Populations
  • Travellers to Endemic Regions

By Distribution Channel

  • Hospitals
  • Clinics
  • Government Immunization Programs

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Anish Swaminathan

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up